https://www.selleckchem.com/pr....oducts/cx-4945-silmi
intervention on CRF management in patients with hematologic cancer. Trial registration clinicaltrials.gov; Trial registration number NCT03403075. Data on feasibility and effect size of TEPA will be analyzed upon completion of Phase II, allowing us to design a large, adequately powered RCT to verify the effectiveness of this intervention on CRF management in patients with hematologic cancer. Trial registration clinicaltrials.gov; Trial registration number NCT03403075.Macular holes are common. Lightening, direct electric sho
Like
Comment
Share
